Surgical and oncological results after surgical treatment of patients diagnosed with sarcoma liver metastases
Por:
González-Abós S., Molina Santos V., Homs Samsó R., Martín Arnau B., Rodríguez Blanco M., González López J.A., López-Pousa A., Moral Duarte A., Sánchez-Cabús S.
Publicada:
1 ene 2023
Ahead of Print:
1 ene 2022
Resumen:
Introduction: The presence of liver metastases in sarcomatous tumors is associated with poor prognosis. However, in selected patients, surgical resection has been suggested as a tool to improve survival rates. The aim of our study is to describe postoperative and oncological outcomes after liver resection. Methods: A retrospective unicentric study was conducted including patients diagnosed with hepatic metastases from soft tissue sarcoma who underwent hepatic resection between 2003 and 2019. The inclusion criteria were the presence of resectable disease, including synchronic and metachronic lesions. The presence of extra-hepatic controlled disease was not considered unresectable. Results: Nineteen patients underwent liver resection for liver metastasis of 7 different sarcomatous subtypes. Median age was 58-yo. Liver metastases were diagnosed a median 25 months after primary tumor diagnosis. Six patients (32%) suffered of synchronic metastases and 12 (63%) were affected of extrahepatic disease. Major hepatectomy was done in 5 (26%) patients, 8 (42%) minor complications were described. Median follow-up was 33 months. Survival analysis was performed independently for, GIST tumors and non-GIST sarcomas. One, three and five-year survival rate was 100%, 85.7% and 42.9% in non-GIST sarcomas, while five and ten-year survival rate was 100% and 40% in GIST, respectively. Conclusions: Surgical approach of liver metastases of sarcomatous tumors seems to be useful in order to improve survival in selected patients, while associated to be of low complications rate. In our cohort, extrahepatic disease rate is high in comparison with series published before, nevertheless survival is comparable. These results support performing surgical resection in selected patients with stable extrahepatic disease. © 2021 AEC
Filiaciones:
González-Abós S.:
Cirugía General, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Molina Santos V.:
Cirugía General, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Homs Samsó R.:
Cirugía General, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Martín Arnau B.:
Cirugía General, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Rodríguez Blanco M.:
Cirugía General, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
González López J.A.:
Cirugía General, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
López-Pousa A.:
Oncología médica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Moral Duarte A.:
Cirugía General, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Sánchez-Cabús S.:
Cirugía General, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
|